₹ 3,304.80
40.90 (1.25%)
G
Gland Pharma
₹ 3,304.80
Gland Pharma EPS Summary (consolidated)
The latest quarterly EPS of Gland Pharma as of Q2 Sep 2026 stands at ₹17.62. This is a 8.37% fall quarter on quarter and 58.03% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹16.84. It beat the estimate by ₹0.78. For the FY2026 the EPS of Gland Pharma stands at ₹62.35. This is a 47.05% growth compared with FY2025.
Gland Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

